ResMed has entered into a definitive agreement to sell its MatrixCare software business to Frazier Healthcare Partners for $490 million. This strategic divestment is intended to sharpen the company's focus on its core sleep health business. MatrixCare contributed approximately $220 million in revenue and $55 million in non-GAAP operating profit for fiscal year 2026.
